Electrochemiluminescence as a Transformative Diagnostic Tool for SARS-CoV-2 Variant Detection: Implications for Future Pandemic Preparedness
ACS Sensors · 11.11.2026
DOI: 10.1021/acssensors.6c01907 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 11.11.2026. Verfasst von Jarid du Plooy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Cape Town, Rondebosch, Cape Town, Western Cape7700, South Africa. Die Arbeit nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, South African Medical Research Council, Council for Scientific and Industrial Research, South Africa.
Abstract (Originalsprache)
Over the past two decades, the three major betacoronavirus outbreaks, SARS-CoV (2002), MERS-CoV (2012), and SARS-CoV-2 (2019), have resulted in millions of infections and deaths globally. SARS-CoV-2 has displayed rapid mutations, enhancing its transmissibility, immune evasion, and resistance to existing vaccines and diagnostics. For these reasons, it has been named the most notorious viral outbreak in modern history. Due to the ever-mutating Spike (S) protein, key interactions with bioreceptors have been disrupted, making conventional detection methods more challenging. To minimize viral spread and improve diagnostic accuracy, innovative biosensing technologies are critical. As such, electrochemiluminescence (ECL) offers a powerful biosensing platform for SARS-CoV-2 variant detection by combining the high sensitivity of optical detection with electrochemistry. Its advantages include culture-independent detection, low background noise, a broad dynamic range, and the ability to detect low viral concentrations. Recent advances in multiple disciplines, such as novel luminophore development, nanotechnology, lab-on-a-chip miniaturization, and AI-driven machine learning, have further enhanced its diagnostic powers. Furthermore, smartphone-integrated ECL platforms enable rapid, point-of-care testing, improving disease surveillance and outbreak response. By uniting AI with ECL biosensing, the diagnostic system can refine variant classification and predict emerging mutations, making ECL a promising candidate for the next generation of pandemic diagnostics. Despite the many advantages, there is limited research that has explored ECL for SARS-CoV-2 variant detection, which is addressed in this review. This review highlights ECL’s potential to become a gold-standard technique for detecting rapidly evolving pathogens, offering a robust and accessible solution for future infectious disease monitoring.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, University of Cape Town, Rondebosch, Cape Town, Western Cape7700, South Africa.
- SensorLab, Department of Chemistry, University of the Western Cape, Bellville, Western Cape7535, South Africa.
ORCID-Profile: Jarid du Plooy, Keagan Pokpas, Samantha Douman
Förderung
- National Research Foundation
- South African Medical Research Council
- Council for Scientific and Industrial Research, South Africa
Zitieren
APA
du Plooy, J., Mokwebo, K. V., Pokpas, K., & Douman, S. (2026). Electrochemiluminescence as a Transformative Diagnostic Tool for SARS-CoV-2 Variant Detection: Implications for Future Pandemic Preparedness. ACS Sensors. https://doi.org/10.1021/acssensors.6c01907
Vancouver
du Plooy J, Mokwebo KV, Pokpas K, Douman S. Electrochemiluminescence as a Transformative Diagnostic Tool for SARS-CoV-2 Variant Detection: Implications for Future Pandemic Preparedness. ACS Sensors. 2026. doi:10.1021/acssensors.6c01907
BibTeX
@article{duPlooy2026,
author = {du Plooy, Jarid and Mokwebo, Kefilwe Vanessa and Pokpas, Keagan and Douman, Samantha},
title = {Electrochemiluminescence as a Transformative Diagnostic Tool for SARS-CoV-2 Variant Detection: Implications for Future Pandemic Preparedness},
journal = {ACS Sensors},
year = {2026},
doi = {10.1021/acssensors.6c01907}
}
EUVIMED